Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
InterDigital
IDCC
$8.83B
| $16.5M | 0.01% |
303,339
+9,535
| +3% | +$527K |
|
1352
Moderna
MRNA
$24B
| $16.5M | 0.01% |
841,776
+22,702
| +3% | +$403K |
|
1353
Hecla Mining
HL
$11.8B
| $16.4M | 0.01% |
4,832,408
+206,925
| +4% | +$508K |
|
1354
SPX Corp
SPXC
$10.9B
| $16.4M | 0.01% |
321,853
+11,369
| +4% | +$520K |
|
1355
Newmark Group
NMRK
$2.61B
| $16.3M | 0.01% |
1,211,384
+95,394
| +9% | +$1.11M |
|
1356
Fox Factory Holding Corp
FOXF
$914M
| $16.3M | 0.01% |
233,888
+4,037
| +2% | +$261K |
|
|
GWB
1357
DELISTED
Great Western Bancorp, Inc.
GWB
| $16.3M | 0.01% |
468,224
+10,925
| +2% | +$377K |
|
1358
Upbound Group
UPBD
$1.12B
| $16.3M | 0.01% |
563,582
+20,272
| +4% | +$530K |
|
1359
Enviri
NVRI
$580M
| $16.2M | 0.01% |
704,959
+3,104
| +0.4% | +$64.9K |
|
|
HTZ
1360
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $16.1M | 0.01% |
1,024,892
+19,379
| +2% | +$290K |
|
|
EVBG
1361
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $16.1M | 0.01% |
206,291
+4,541
| +2% | +$351K |
|
|
CUB
1362
DELISTED
Cubic Corporation
CUB
| $16.1M | 0.01% |
252,955
-606
| -0.2% | -$41K |
|
|
FOLD
1363
DELISTED
Amicus Therapeutics
FOLD
| $16.1M | 0.01% |
1,650,776
+107,210
| +7% | +$981K |
|
1364
Buckle
BKE
$2.37B
| $16.1M | 0.01% |
593,688
-14,163
| -2% | -$337K |
|
1365
Valmont Industries
VMI
$9.64B
| $16M | 0.01% |
107,003
+965
| +0.9% | +$136K |
|
|
VGR
1366
DELISTED
Vector Group Ltd.
VGR
| $16M | 0.01% |
1,687,331
+28,914
| +2% | +$253K |
|
|
ARNA
1367
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $16M | 0.01% |
352,744
+766
| +0.2% | +$36.2K |
|
1368
Capitol Federal Financial
CFFN
$1.09B
| $16M | 0.01% |
1,162,794
+18,880
| +2% | +$266K |
|
1369
Walker & Dunlop
WD
$1.5B
| $16M | 0.01% |
246,742
+8,238
| +3% | +$521K |
|
1370
Box
BOX
$4.58B
| $15.9M | 0.01% |
949,790
-31,621
| -3% | -$530K |
|
|
MNDT
1371
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $15.9M | 0.01% |
963,973
+24,519
| +3% | +$393K |
|
1372
Interactive Brokers
IBKR
$40.7B
| $15.9M | 0.01% |
1,363,956
+33,708
| +3% | +$396K |
|
|
SYKE
1373
DELISTED
SYKES Enterprises Inc
SYKE
| $15.9M | 0.01% |
429,505
-1,488
| -0.3% | -$50.3K |
|
1374
AMC Global Media
AMCX
$485M
| $15.9M | 0.01% |
401,826
+23,492
| +6% | +$987K |
|
1375
Texas Capital Bancshares
TCBI
$4.36B
| $15.9M | 0.01% |
279,423
+8,906
| +3% | +$508K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.